Journal of the Chinese Medical Association
Volume 70, Issue 5 , Pages 193-199, May 2007

Outcome of Kidney Transplantation Using Organs from Executed Prisoners: Is It Justified Beyond the Ethical Issue?

  • Kuo-Hsiung Shu

      Affiliations

    • Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • School of Medicine, Chung-Shan Medical University, Taichung, Taiwan, R.O.C.
    • Corresponding Author InformationCorrespondence to: Dr Kuo-Hsiung Shu, Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital, 160, Section 3, Chung-Kang Road, Taichung 407, Taiwan, R.O.C.
    • ,
  • Ming-Ju Wu

      Affiliations

    • Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • School of Medicine, Chung-Shan Medical University, Taichung, Taiwan, R.O.C.
    • ,
  • Cheng-Hsu Chen

      Affiliations

    • Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • ,
  • Chi-Hung Cheng

      Affiliations

    • Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.
    • School of Medicine, Chung-Shan Medical University, Taichung, Taiwan, R.O.C.
    • ,
  • Jong-Da Lian

      Affiliations

    • School of Medicine, Chung-Shan Medical University, Taichung, Taiwan, R.O.C.
    • Division of Nephrology, Department of Medicine, Taichung, Taiwan, R.O.C.

Received 3 July 2006; accepted 9 April 2007.

Article Outline

Background

Kidney transplantation using organs from executed prisoners is a subject of controversy from the viewpoint of ethics. However, few reports have addressed the clinical outcome beyond the ethical issue.

Methods

Between January 1990 and September 2004, a total of 435 kidney transplant recipients (group M) who underwent transplantation in 26 different hospitals in China were followed up at our hospital. It is believed that all the organs came from executed prisoners. The clinical data were retrieved and compared to those of 200 kidney transplant recipients (group T) who underwent transplantation in our hospital during the same period.

Results

There was no significant difference between these 2 groups (T vs. M) in terms of hepatitis B virus infection (10.5% vs. 12.1%) or surgical complication rate (6.5% vs. 5.6%). The 1st-year acute rejection rate was significantly lower in group M (31.1% vs. 24.5%, p = 0.015). The 1-year, 5-year, and 10-year patient survival rates were 94.3%, 89.5%, and 85.2%, respectively, for group T and 92.6%, 83.6%, and 76.7%, respectively, for group M (p > 0.05); the corresponding graft survival rates were 91.4%, 82.6%, and 66.9%, respectively, for group T and 91.6%, 80.0%, and 61.4%, respectively, for group M (p > 0.05). When patients were stratified according to the year of transplantation, patients who underwent transplantation between 2000 and 2004 had significantly better graft survival rates in both groups.

Conclusion

We conclude that kidney transplantation using organs from executed prisoners had a clinical outcome similar to that of transplantation performed in our hospital during the same period.

Key Words:  executed prisoner , kidney transplantation , organ donation

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. US Renal Data System Annual Report, 2005. International comparison 2005.
  2. Briggs JD . The use of organs from executed prisoners in China . Nephrol Dial Transplant . 1996;11:238–240
  3. Cameron JS , Hoffenberg R . The ethics of organ transplantation reconsidered: paid organ donation and the use of executed prisoners as donors . Kidney Int . 1999;55:724–732
  4. Miller RB . Ethics of paid organ donation and the use of executed prisoners as donors: a dialectic with professors Cameron and Hoffenberg . Kidney Int . 1999;55:733–737
  5. Cheng IK , Lai KN , Au TC , Chan PS , Poon GP , Chan YT . Comparison of the mortality and morbidity rates between proper and unconventional renal transplantation using organs from executed prisoners . Transplant Proc . 1991;23:2533–2536
  6. Kennedy SE, Shen Y, Charlesworth JA, Mackie JD, Mahony JD, Kelly JJ, et al. Outcome of overseas commercial kidney transplantation: an Australian perspective . Med J Aust . 2005;182:224–227
  7. Malyszko J , Malyszko JS , Bachorzewska-Gajewska H . Cardiovascular risk in chronic renal disease and transplantation prevention and management . Expert Opin Pharmacother . 2005;6:929–943
  8. Opelz G , for the Collaborative Transplant Study  . HLA matching in Asian recipients of kidney grafts from unrelated living or cadaveric donors . Hum Immunol . 2000;61:115–119
  9. Morris PJ , Johnson RJ , Fuggle SV , Belger MA , Briggs JD . Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA Task Force of the Kidney Advisory Group of the United Kingdom Transplant Support Service Authority (UKTSSA) . Lancet . 1999;354:1147–1152
  10. Su X , Zenios SA , Chakkera H , Milford EL , Chertow GM . Diminishing significance of HLA matching in kidney transplantation . Am J Transplant . 2004;4:1501–1508
  11. Gill JS , Tonelli M , Johnson N , Pereira BJ . Why do preemptive kidney transplant recipients have an allograft survival advantage? . Transplantation . 2004;78:873–879
  12. Mange KC , Weir MR . Preemptive renal transplantation: why not? . Am J Transplant . 2003;3:1336–1340
  13. Goldfarb-Rumyantzev A, Hurdle JF, Scandling J, Wang Z, Baird B, Barenbaum L, et al. Duration of end-stage renal disease and kidney transplant outcome . Nephrol Dial Transplant . 2005;20:167–175
  14. Webster AC , Woodroffe RC , Taylor RS , Chapman JR , Craig JC . Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data . Br Med J . 2005;331:810
  15. Ciancio G , Miller J , Gonwa TA . Review of major clinical trials with mycophenolate mofetil in renal transplantation . Transplantation . 2005;80(Suppl):191–200
  16. Hariharan S , Johnson CP , Bresnahan BA , Taranto SE , McIntosh MJ , Stablein D . Improved graft survival after renal transplantation in the United States, 1988 to 1996 . N Engl J Med . 2000;342:605–612
  17. Sung JL . Hepatitis B virus infection and its sequelae in Taiwan . Proc Natl Sci Council ROC . 1981;5:385–399
  18. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al  Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination . Ann Intern Med . 2001;135:796–800
  19. Chan CY , Lee SD , Lo KJ . Legend of hepatitis B vaccination: the Taiwan experience . J Gastroenterol Hepatol . 2004;19:121–126
  20. Lee WC , Wu MJ , Cheng CH , Chen CH , Shu KH , Lian JD . Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients . Am J Kidney Dis . 2001;38:1074–1081
  21. Shu KH, Lan JL, Wu MJ, Cheng CH, Chen CH, Lee WC, et al  Ultralow-dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients . Transplantation . 2004;77:1894–1896
  22. Yang TC , Shu KH , Cheng CH , Wu MJ , Lian JD . Malignancy following renal transplantation . J Chin Med Assoc . 1998;61:281–288

PII: S1726-4901(09)70357-0

doi:10.1016/S1726-4901(09)70357-0

Journal of the Chinese Medical Association
Volume 70, Issue 5 , Pages 193-199, May 2007

Article Tools